Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
In vascular disease states such as atherosclerosis and diabetes, endothelial nitric oxide (NO) bioactivity is reduced and oxidative stress is increased, resulting in endothelial dysfunction. Recent studies suggest that changes in the activity and regulation of endothelial NO synthase by its cofactor...
Autor principal: | Channon, K |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2004
|
Ítems similars
-
Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
per: Alp, N, et al.
Publicat: (2004) -
Regulation of endothelial nitric oxide synthase (eNOS) by tetrahydrobiopterin in vascular disease
per: Alp, N, et al.
Publicat: (2004) -
Tetrahydrobiopterin and nitric oxide synthase recouplers
per: Channon, KM
Publicat: (2020) -
Prevention of hypoxia-induced pulmonary hypertension and vascular remodelling by targeting endothelial tetrahydrobiopterin-dependent nitric oxide synthase regulation
per: Khoo, J, et al.
Publicat: (2005) -
Endothelial tetrahydrobiopterin deficiency accelerates atherosclerotic progression by nitric oxide synthase uncoupling
per: Khoo, J, et al.
Publicat: (2005)